SureTrader Advertisement SureTrader
Home > Boards > US Listed > Biotechs > Rosetta Genomics Ltd (ROSG)

RSI still at 66.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Penny Gold Mine Member Profile
Member Level 
Followed By 212
Posts 6,822
Boards Moderated 2
Alias Born 12/14/09
160x600 placeholder
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 3/31/2016 6:01:48 AM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) "Edgar (US Regulatory)" - 3/30/2016 5:58:50 PM
Securities Registration (foreign Private Issuer) (f-3) "Edgar (US Regulatory)" - 3/23/2016 4:46:34 PM
Rosetta Genomics Reports 2015 Full Year Financial Results "Business Wire" - 3/23/2016 4:05:00 PM
Rosetta Genomics to Host Business Update and 2015 Year-End Financial Results Conference Call on March 23, 2016 "Business Wire" - 3/17/2016 8:30:00 AM
Statement of Beneficial Ownership (sc 13d) "Edgar (US Regulatory)" - 3/4/2016 4:06:17 PM
Rosetta Genomics Appoints Ana C. Ward as Executive Vice President, Legal and Corporate Development "Business Wire" - 2/29/2016 9:00:00 AM
Rosetta Genomics Expands Molecular Diagnostics Test Menu with Launch of Three New Product Offerings "Business Wire" - 2/25/2016 9:00:00 AM
Rosetta Genomics Receives Approval from New York State for First-of-its-kind Thyroid Cancer Diagnostic Assay "Business Wire" - 2/18/2016 9:00:00 AM
Rosetta Genomics to Present at Source Capital's 2016 Disruptive Growth & Healthcare Conference "Business Wire" - 2/8/2016 8:00:00 AM
Rosetta Genomics Announces Agreement with America’s Choice Provider Network for Entire Suite of Diagnostic Tests and Services "Business Wire" - 2/1/2016 8:00:00 AM
Rosetta Genomics Granted U.S. Patent Allowance for Use of Gene Expression Signature for Classification of Kidney Tumors "Business Wire" - 1/25/2016 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/19/2016 4:08:02 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/14/2016 2:48:03 PM
CORRECTING & REPLACING Rosetta Genomics Granted EPO Patent Allowance for Use of microRNA Molecules for the Treatment of Liver... "Business Wire" - 1/11/2016 10:19:00 AM
Rosetta Genomics Granted U.S. Patent Allowance for Use of microRNA Molecules for the Treatment of Liver Cancer "Business Wire" - 1/11/2016 9:11:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 1/6/2016 4:51:32 PM
Rosetta Genomics Grants Sublicenses to Mirna Therapeutics for microRNA-related Patents for the Development of Oncology Therap... "Business Wire" - 1/6/2016 8:00:00 AM
Rosetta Genomics & Biocept Advance Collaboration to Proof-of-Concept Studies Aimed at microRNA Profiling of Circulating Tumor... "Business Wire" - 12/14/2015 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/3/2015 12:00:46 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/3/2015 7:01:24 AM
Rosetta Genomics Reports Third Quarter 2015 Financial Results "Business Wire" - 12/1/2015 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/1/2015 7:51:56 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 11/23/2015 5:09:35 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 11/23/2015 11:45:04 AM
Penny Gold Mine Member Level  Thursday, 05/31/12 08:32:15 AM
Re: None
Post # of 1858 
RSI still at 66.

needs to cool off still for next run.IMO

11 may be enough

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist